FDA.reportPublic FDA data

Neupro Titration Kit for Parkinson's disease Pack

RxCUI
1360633
RxNorm name
Neupro Titration Kit for Parkinson's disease Pack
Display name
Neupro Titration Kit for Parkinson's disease Pack
Full name
Neupro Titration Kit for Parkinson's disease Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0{7 (24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System [Neupro]) } Pack [Neupro Kit] [BPCK] · Neupro Titration Kit for Parkinson's disease Pack [PSN] · Neupro Titration Kit for Parkinson's disease [SY]320These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624